Choe Il-son of Korea DPR headlines the winners of the FIFA U-20 Women's World Cup Colombia 2024 awards. Korea DPR's Choe Il-son wins both the adidas Golden Ball as Colombia 2024's outstanding ...
Chlorine, other pool chemicals, and ocean water can affect eczema. Eczema is a group of noncontagious skin conditions that cause inflamed skin. Atopic dermatitis is the most common type of eczema.
17, 2024 (HealthDay News) -- Millions more people will die annually from antibiotic-resistant infections over the next 25 years unless steps are taken to counter this growing health threat, a new ...
Corporate commitments to increase the number of women in the leadership pipeline are slipping amid mounting attacks on diversity, equity and inclusion. Employers surveyed by LeanIn.org and ...
According to the latest Women in the Workplace report from Lean In and McKinsey, many of the tactics experts and scholars have been recommending to company leaders for years have been paying off ...
Women hold more of the top jobs in companies than ever before, but they lag behind men on crucial early promotions into management—holding them back from greater power at work. That’s one of ...
Whether you're looking to splurge or save, we have options from Summersalt, Amazon, and Aerie.
Carlos Duarte via Getty Images More than 39 million people around the globe could die because of antibiotic-resistant infections between 2025 and 2050—a statistic that equates to about three ...
Infections of drug-resistant superbugs are projected to kill nearly 40 million people over the next 25 years, a global analysis predicted on Monday, as the researchers called for action to avoid this ...
More than 39 million people could die of antibiotic-resistant infections between now and 2050, according to a study published Monday in The Lancet. The authors of the study forecast a nearly 70 ...
In the last six months alone, malicious emails have increased by 341%, prompting industry experts to urge organizations of all sizes to implement phishing-resistant MFA. So, what is phishing-resistant ...
Hugh Griffith, NuCana's Founder and CEO, said, "We are very excited to share these data on NUC-7738 in combination with pembrolizumab in PD-1 inhibitor refractory and resistant patients with melanoma.